Arcus Biosciences, Inc. - stock earnings

RCUS Quarterly earnings

DateEarningsRevenue
2023Q4 -81.0 million USD 31.0 million USD
2023Q3 -71.0 million USD 32.0 million USD
2023Q2 -75.0 million USD 29.0 million USD
2023Q1 -80.0 million USD 25.0 million USD
2022Q4 -67.0 million USD 345000 USD
2022Q3 -60.4 million USD 33.6 million USD
2022Q2 -64.3 million USD 26.8 million USD
2022Q1 -68.0 million USD 18.0 million USD
2021Q4 279.4 million USD 354.5 million USD
2021Q3 -78.0 million USD 9.5 million USD
2021Q2 -76.0 million USD 9.5 million USD
2021Q1 -72.6 million USD 9.5 million USD
2020Q4 -51.9 million USD 9.5 million USD
2020Q3 1.8 million USD 64.5 million USD
2020Q2 -45.1 million USD 1.8 million USD
2020Q1 -27.8 million USD 1.8 million USD
2019Q4 -16.6 million USD 9.8 million USD
2019Q3 -22.4 million USD 1.8 million USD
2019Q2 -28.1 million USD 1.8 million USD
2019Q1 -17.7 million USD 1.8 million USD
2018Q4 -12.3 million USD 1.6 million USD
2018Q3 -10.8 million USD 4.3 million USD
2018Q2 -13.5 million USD 1.3 million USD
2018Q1 -13.0 million USD 1.3 million USD
2017Q4 -13.2 million USD 1.3 million USD
2017Q3 -23.1 million USD 163000 USD
2017Q2 -9.6 million USD ? USD
2017Q1 -7.2 million USD ? USD
2016Q4 -18.0 million USD ? USD

RCUS Yearly earnings

DateEarningsRevenue
2023 -307.0 million USD 117.0 million USD
2022 -267.0 million USD 112.0 million USD
2021 53.0 million USD 382.9 million USD
2020 -116.7 million USD 77.5 million USD
2019 -75.9 million USD 15.0 million USD
2018 -49.6 million USD 8.4 million USD
2017 -53.1 million USD 1.4 million USD
2016 -18.0 million USD ? USD

RCUS

Price: $15.23

52 week price:
12.95
25.47

Earnings Per Share: -4.15 USD

P/E Ratio: -3.83

Exchange: NYQ

Sector: Healthcare

Industry: Biotechnology

Volume: 965900

Market Capitalization: 1.6 billion

Links: